Found: 117
Select item for more details and to access through your institution.
Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole blood.
- Published in:
- Prostate, 2024, v. 84, n. 9, p. 850, doi. 10.1002/pros.24704
- By:
- Publication type:
- Article
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis.
- Published in:
- Endocrine (1355008X), 2024, v. 84, n. 2, p. 704, doi. 10.1007/s12020-024-03707-5
- By:
- Publication type:
- Article
Sequencing of Somatostatin-Receptor--Based Therapies in Neuroendocrine Tumor Patients.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 340, doi. 10.2967/jnumed.123.265706
- By:
- Publication type:
- Article
Sequencing of Somatostatin-Receptor--Based Therapies in Neuroendocrine Tumor Patients.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.265706
- By:
- Publication type:
- Article
Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 2, p. 325, doi. 10.1007/s00259-023-06420-z
- By:
- Publication type:
- Article
Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1779, doi. 10.2967/jnumed.123.265763
- By:
- Publication type:
- Article
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1001, doi. 10.1093/jnci/djad096
- By:
- Publication type:
- Article
SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1417, doi. 10.2967/jnumed.123.265952
- By:
- Publication type:
- Article
Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 567, doi. 10.2967/jnumed.122.264363
- By:
- Publication type:
- Article
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 204, doi. 10.2967/jnumed.122.264860
- By:
- Publication type:
- Article
The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the Field.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 219, doi. 10.2967/jnumed.122.264805
- By:
- Publication type:
- Article
From Physician to Leader in Global Research and Development: A Conversation Between Ken Song, Lisa Bodei, and Johannes Czernin.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 8, doi. 10.2967/jnumed.122.265135
- By:
- Publication type:
- Article
Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE.
- Published in:
- Neuroendocrinology, 2022, v. 112, n. 12, p. 1177, doi. 10.1159/000525216
- By:
- Publication type:
- Article
The Future of Targeted Alpha Therapy is Bright but Rigorous Studies are Necessary to Advance the Field.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264805
- By:
- Publication type:
- Article
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 3, p. 1, doi. 10.1111/jne.13040
- By:
- Publication type:
- Article
Landscape analysis of Phase 2/3 clinical trials for Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258103
- By:
- Publication type:
- Article
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.251512
- By:
- Publication type:
- Article
The quest for an accurate functional tumor volume with <sup>68</sup>Ga-DOTATATE PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262782
- By:
- Publication type:
- Article
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7506, doi. 10.1245/s10434-021-10021-1
- By:
- Publication type:
- Article
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 12, p. 4016, doi. 10.1007/s00259-021-05359-3
- By:
- Publication type:
- Article
Landscape analysis of Phase 2/3 clinical trials for Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258103
- By:
- Publication type:
- Article
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.251512
- By:
- Publication type:
- Article
Landscape analysis of Phase 2/3 clinical trials for Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258103
- By:
- Publication type:
- Article
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.251512
- By:
- Publication type:
- Article
Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma.
- Published in:
- Journal of the Endocrine Society, 2021, v. 5, n. 10, p. 1, doi. 10.1210/jendso/bvab133
- By:
- Publication type:
- Article
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 10, p. 3260, doi. 10.1007/s00259-021-05236-z
- By:
- Publication type:
- Article
Imaging of neuroendocrine tumors: A pictorial review of the clinical value of different imaging modalities.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2021, v. 22, n. 3, p. 539, doi. 10.1007/s11154-021-09631-7
- By:
- Publication type:
- Article
Landscape analysis of Phase 2/3 clinical trials for Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258103
- By:
- Publication type:
- Article
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.251512
- By:
- Publication type:
- Article
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 8, p. 2642, doi. 10.1007/s00259-020-05150-w
- By:
- Publication type:
- Article
Landscape analysis of Phase 2/3 clinical trials for Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258103
- By:
- Publication type:
- Article
Landscape analysis of Phase 2/3 clinical trials for Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 29, doi. 10.2967/jnumed.120.258103
- By:
- Publication type:
- Article
Landscape analysis of Phase 2/3 clinical trials for Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258103
- By:
- Publication type:
- Article
Landscape analysis of Phase 2/3 clinical trials for Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.258103
- By:
- Publication type:
- Article
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 13, p. 3047, doi. 10.1007/s00259-020-04832-9
- By:
- Publication type:
- Article
Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Gamma-Tocotrienol loaded liposomes as radioprotection from hematopoietic side effects caused by radiotherapeutic drugs.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244681
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Gamma-Tocotrienol loaded liposomes as radioprotection from hematopoietic side effects caused by radiotherapeutic drugs.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244681
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Gamma-Tocotrienol loaded liposomes as radioprotection from hematopoietic side effects caused by radiotherapeutic drugs.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244681
- By:
- Publication type:
- Article
A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigm.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 10, p. 2358, doi. 10.1007/s00259-020-04712-2
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Gamma-Tocotrienol loaded liposomes as radioprotection from hematopoietic side effects caused by radiotherapeutic drugs.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244681
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2020, v. 57, n. 6, p. 1195, doi. 10.1093/ejcts/ezaa018
- By:
- Publication type:
- Article
Neuroendocrine Neoplasms of the Small Bowel and Pancreas.
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 6, p. 444, doi. 10.1159/000503721
- By:
- Publication type:
- Article
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 4, p. 895, doi. 10.1007/s00259-019-04601-3
- By:
- Publication type:
- Article